Retinopathy of prematurity (ROP) is a potentially blinding ocular disorder that is unique to the preterm infant. The current epidemic affects the smallest and illest preterm survivors of modern neonatal intensive care units. With the prevention of neonatal asphyxia, judicious curtailment of oxygen, and adequate doses of vitamin E, ROP has become a disorder that is generally restricted to infants weighing less than 1001 g at birth. The size of the surviving population of infants with ROP dwarfs all previous predictions of absolute numbers because survival rates of infants weighing 501-750 g at birth are now approaching 60%, and those of infants weighing 751-1000 g are now approaching 90%.
Retinopathy of prematurity (ROP) is a potentially blinding ocular disorder that is unique to the preterm infant. The current epidemic affects the smallest and illest preterm survivors of modern neonatal intensive care units. With the prevention of neonatal asphyxia, judicious curtailment of oxygen, and adequate doses of vitamin E, ROP has become a disorder that is generally restricted to infants weighing less than 1001 g at birth. The size of the surviving population of infants with ROP dwarfs all previous predictions of absolute numbers because survival rates of infants weighing 501-750 g at birth are now approaching 60%, and those of infants weighing 751-1000 g are now approaching 90%.
The total incidence of ROP in infants weighing 501-750 g is almost 100% with severe ROP developing in about 30%. The total incidence of ROP in infants weighing 751-1000 g is almost 80% with severe ROP developing in about 10%. Whether the future total incidence of ROP and that of severe ROP will change is dependent on the unknown effects of the many new developments in the care of premature infants.
NORMAL RETINAL DEVELOPMENT
The immature retina has two blood supplies, the choroidal vessels and the inner retinal vessels (fig 1) Spindle cells migrate in the inner retina from the optic disc to the ora serrata (figs 1 and 2). Spindle cells appear round the optic disc at 16 weeks' gestation and reach the ora serrata at 29 weeks' gestation (a total transit time of 13 weeks). After 29 weeks' gestation the spindle cell apron continually decreases in its linear extent so that the spindle cell apron has completely disappeared and the inner retinal vasculature is completely formed at 40 weeks' gestation. In the smallest infants the proximal portion of the spindle cell apron is intermingled with the formed vessels, and a few spindle cells may even remain in the adventitia of the hyaloid artery at the optic disc; in larger infants the spindle cell apron is not intermingled with the formed vessels, and spindle cells do not remain at the optic disc. A small region of the spindle cell apron anterior to the last formed vessels continues the inner retinal vasculature by canalisation.
The transretinal geometry between the slowly migrating spindle cells (13 weeks The macula is a specialised region of the posterior retina that is responsible for all fine visual acuity ( fig 1) . It is an avascular region in which the inner retina is displaced circumferentially 3600 so that light can impinge perpendicularly on the perfectly parallel discs of the cone photoreceptors. The commitment to macular development and its subsequent remodelling must be triggered by an interplay between the inner/outer vector. This region is incompletely developed until three months after birth in an infant born at full term. Clinically the macula appears immature before this time-that is, it does not have a dimpled appearance.
The distance between the temporal rim of the optic disc and the centre of the macula is constant in all normally developing or developed human eyes. With the development of severe ROP the distance between the temporal rim of the optic disc and the centre of the macula may be increased by dragging, whether the ROP regresses spontaneously or is treated successfully by cryotherapy.
OCULAR GROWTH
As the retina develops along the central/peripheral and inner/outer vectors with macular remodelling, the overall diameter of the globe increases rapidly with only 15% of the increase in the diameter of the globe occurring after40weeks'gestation (figs 1 and 4 There have been four randomised, masked controlled clinical trials to evaluate the effect of prophylaxis with vitamin E on the suppression of the development of severe ROP (table 2) .12-15 The protocol for each trial was designed so that vitamin E should be given from the first day of life and should be continued without interruption until inner retinal vascularisation was complete. Each used different vitamin E preparations, achieved different plasma vitamin E concentrations, used a different initial route of administration, evaluated ROP by different classification systems, set different end points for analysis, and had different percentages of infants lost to follow up.
The three clinical trials in which prophylaxis with vitamin E was shown to be effective may be explained by the spindle cell/myofibroblast pathogenesis of ROP. Early and continuous vitamin E supplementation resulted in sufficient retinal uptake to stabilise spindle cell membranes against free radical damage in almost all infants weighing 1001-1500 g at birth. This supplementation also partially protected most extremely high risk infants (those weighing 1000 g or less at birth) unless several risk factors were present. Johnson et al in their initial report took one year as their end point, which allowed exclusion of a few totally blind infants in the control group who died before 1 year of age. 16 The single trial in which prophylaxis with vitamin E was not shown to be effective15 may also be explained by the spindle cell/myofibroblast pathogenesis of ROP. The initial, rapid intravenous infusion may have resulted in delayed uptake into the retina caused by sequestration by the liver of the transiently high plasma vitamin E concentrations. 19 The committee concluded that there was no definite evidence of either benefit or harm from prophylaxis with vitamin E against ROP, and that the risks of giving vitamin E seem to be minimal for premature infants provided that the doses are kept low enough to achieve a blood concentration of no higher than 3 mg%.
Our personal clinical experience since 1979 with vitamin E prophylaxis is more favourable. No infant who weighed greater than 1001 g at birth, who received vitamin E according to our protocol, and who did not have severe hypoxia during delivery or severe hypotension with subsequent reperfusion, has developed severe ROP. Thus a sufficient retinal uptake of plasma vitamin E must be stabilising most of the spindle cell apron and halting the cascade of events that may ultimately result in traction and retinal detachment. The development of severe ROP in infants weighing 1000 g or less at birth is delayed. Insufficient retinal uptake of plasma vitamin E caused by there being insufficient amounts of interstitial retinol binding protein in the subretinal space may only transiently suppress formation of gap junctions between spindle cells in the inner retina. Thus in the smallest and illest infants, prophylaxis with vitamin E may ultimately fail to prevent sufficient spindle cell membrane damage. Severe ROP develops about two weeks later than in similar infants not receiving vitamin E.
The overall incidence of all stages of ROP is not decreasing because the protection given to plasma membranes by vitamin E is not an 'all or nothing' effect, and is by no means a panacea. Vitamin E prophylaxis is drastically decreasing the severity of ROP in infants weighing between 1001 and 1500 g at birth.
The Fig 6 Top: preoperative appearance at the age of10 weeks ofright retina ofan infant weighing 650 g at birth with zone II stage 3+ ROP. Note the extent of vascularised retina (distance between the pair ofthree vertical dashes equals 2*5 cm of retina); and immature macula (circle); and the distance between the temporal rim ofthe optic disc (two vertical dashes) and the centre of the macula equals 0-5 cm ofretina). Moderate plus disease and moderate invasion ofmyofibroblast are present.
Bottom: postoperative appearance ofthe same eye at the age of10 months. Note extent of viable retina (distance between the pair ofthree double vertical dashes equals 1 9 cm of retina); temporally displaced macula (circle); and distance between the temporal rim ofthe optic disc (two vertical dashes) and centre ofthe macula equals 0-7 cm of retina. Dragging ofposterior vessels and the region offull thickness cryotherapy are visible. Fixation is unsteady (nystagmus) in this myopic (-9 00) eye at the age of21 months. Comparison ofthese two retinal montages shows that cryotherapy to the avascular retina and shunt alone do not guarantee a favourable outcome with respect to macularfunction. dragging of the larger retinal vessels, or of the macula. REGRESSION top, fig 7 top, fig 8 top) . Histologically a surge of myofibroblast sheets differentiate from the shunt and invade the vitreous (fig 9) . THE Fig 7 Top : preoperative appearance at the age of 10 weeks ofthe right retina ofan infant weighing 880 g at birth, with zone II stage 3+ ROP. Note the extent of vascularised retina (distance between the pair of three vertical dashes equals 2-4 cm of retina); and immature macula (circle); and the distance between the temporal rim ofthe optic disc (two vertical dashes) and the centre ofthe macula equals 0-5 cm of retina. Severe plus disease and an area ofhaemorrhage adjacent to severe invasion ofmyofibroblasts are visible. Bottom: postoperative appearance ofthe same eye at the age of20 months. Note temporally displaced, abnormally pigmented macula (circle), the distance between the temporal rim ofthe optic disc (two vertical dashes) and the centre ofthe macula equals 0-6 cm ofretina, and the anterior extent of the therapeutic scleral buckle (wide solid circular line). Fixation is unsteady (nystagmus) in this myopic (-9.50) eye. Comparison of these two retinal montages shows that cryotherapy to the avascular retina and shunt alone did notprevent retinal detachment, and that a therapeutic scleral buckle does not permit a favourable outcome with respect to macularfunction. Destroy the spindle cell apron that is the source of angiogenic factors. This part of our current protocol is identical to that recommended by the collaborative study except that we treat both eyes when symmetrical disease is present. Clinically, within a day or two after cryotherapy to the avascular retina, the posterior retinal vessels become less dilated and tortuous, the shunt empties of blood, and the sheets of myofibroblasts atrophy.
Destroy the shunt and sheets of myofibroblasts that are the source of traction leading to macular dragging or retinal detachment. This second cryotherapy to the shunt and sheets of myofibroblasts (optimally some three to seven days after the initial cryotherapy to the avascular retina) will produce less haemorrhage than might be produced if the shunt and sheets of myofibroblasts are inadvertently treated during the initial cryotherapy. The two treatments may be sufficient to prevent retinal detachment in some cases, but do not prevent dragging of the macula (fig 6 bottom) . The two cryotherapies, however, may not in many cases be sufficient to prevent retinal detachment, and a therapeutic scleral buckle may be required to reattach the retina (fig 7 bottom) .
Place a prophylactic scleral buckle at the site of the former shunt at the time of the second cryotherapy. With continued growth of the anterior portion of the eye, this band changes the general shape of the eye from a sphere to an ellipse so that the posterior portion of the eye in which the macula resides is not dragged. Additionally, this band counterbalances tractional forces from the active contraction of sheets of myofibroblasts or from a fixed inactive remnant myofibroblast ridge that can lead to retinal detachment even when the shunt has been obliterated.
This staged procedure seems to allow the macula to develop maximally without distortion from dragging or detachment, and visual acuity is usually better than 20/40 (fig 8 bottom) . When myofibroblasts have completely disappeared from the vitreous, complete quiescence of ROP has been obtained.
When ocular growth is complete (at about 18 months), it is usually safe to remove the scleral buckle and permit the eye to return to its normal spherical shape.
As successful as these drastic operations may be,
